EUVIMEDEUVIMED entdecken
Crossref

Comparative Assessment of Lesion Severity, Pain Reduction, And Adverse Effects of Topical Coconut Cream and Clobetasol Propionate 0.05% in Oral Lichen Planus: A Randomized Double-Blind Clinical Trial

Upasana Pal

International Journal of Current Pharmaceutical Review and Research · 31.03.2026 · 18 (03)

DOI: 10.25258/ijcpr.18.3.282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.03.2026. Verfasst von Upasana Pal.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral lichen planus (OLP) is a chronic, immune-mediated mucocutaneous disorder that poses a significant therapeutic challenge due to its relapsing nature. Clobetasol propionate 0.05% ointment remains the gold standard for topical management; however, its prolonged use is associated with undesirable side effects including mucosal atrophy and secondary candidal infection. Coconut cream, rich in medium-chain fatty acids with established anti-inflammatory and immunomodulatory properties, presents a promising natural alternative. This study aimed to compare the clinical efficacy and safety of topical coconut cream versus clobetasol propionate 0.05% ointment in patients with symptomatic OLP over an eight-week period.

Methods

A double-blinded randomized controlled trial was conducted on 84 histopathologically confirmed OLP patients recruited from a tertiary dental institution. Participants were randomly allocated into two equal groups (n=42 each): Group A received topical coconut cream and Group B received clobetasol propionate 0.05% ointment, applied three times daily for eight weeks. Clinical outcomes were assessed at baseline, Week 2, Week 4, and Week 8 using the Thongprasom sign scoring criteria and the Visual Analogue Scale (VAS) for pain. Adverse effects were monitored throughout the study.

Results

Both groups demonstrated statistically significant reductions in lesion severity and pain scores from baseline. The clobetasol group achieved a greater mean reduction in Thongprasom score (69.5% vs. 60.5%, p=0.031) and VAS pain score (79.5% vs. 70.6%, p=0.018) compared to the coconut cream group at eight weeks. However, the adverse effect profile favoured coconut cream significantly (9.5% vs. 33.3%, p=0.012), with no cases of oral candidiasis or mucosal atrophy in Group A.

Conclusion

Clobetasol propionate demonstrated superior short-term efficacy in reducing OLP lesion severity and pain; however, topical coconut cream offered clinically meaningful improvement with a substantially safer adverse effect profile. Coconut cream may serve as a viable alternative in patients intolerant to corticosteroids or in mild-to-moderate presentations of OLP.

Zitieren

APA

Pal, U. (2026). Comparative Assessment of Lesion Severity, Pain Reduction, And Adverse Effects of Topical Coconut Cream and Clobetasol Propionate 0.05% in Oral Lichen Planus: A Randomized Double-Blind Clinical Trial. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.282

Vancouver

Pal U. Comparative Assessment of Lesion Severity, Pain Reduction, And Adverse Effects of Topical Coconut Cream and Clobetasol Propionate 0.05% in Oral Lichen Planus: A Randomized Double-Blind Clinical Trial. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.282

BibTeX
@article{Pal2026,
  author = {Pal, Upasana},
  title = {Comparative Assessment of Lesion Severity, Pain Reduction, And Adverse Effects of Topical Coconut Cream and Clobetasol Propionate 0.05% in Oral Lichen Planus: A Randomized Double-Blind Clinical Trial},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {03},
  doi = {10.25258/ijcpr.18.3.282}
}
Kostenlos starten →